Company intelligence / Profile preview

Advantice Health

Bridgewater, New Jersey, United Statesadvanticehealth.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Advantice Health markets a portfolio of science-backed over-the-counter therapeutic skincare brands. Their leading brands—AmLactin (moisturizers for dry skin), Kerasal/Kerasal Nail (foot/nail care), Triple Paste (diaper rash cream), Dermoplast (pain & itch relief spray), New Skin (liquid bandage/wound care), Emtrix/Zanmira—are widely available in retail stores and online. The company does not conduct clinical trials typical of prescription drug development but relies on established efficacy of its formulations for consumer use.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small moleculeDeviceNon-pharmacological therapy
Industry: Biotech

Drug pipeline

3 assets

Dermoplast

Unknown

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Advantice Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advantice Health.

Explore the full profile